메뉴 건너뛰기




Volumn 2, Issue 2, 2011, Pages 45-58

A review of the safety of anticoagulants in older people using the medicines management pathway: Weighing the benefits against the risks

Author keywords

anticoagulant; atrial fibrillation; medication safety; medicines management pathway; risk assessment; risk benefit assessment; stroke prevention; warfarin

Indexed keywords


EID: 84993660749     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098611400495     Document Type: Review
Times cited : (24)

References (79)
  • 1
    • 29244449925 scopus 로고    scopus 로고
    • The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation
    • Bajorek B.V. Krass I. Ogle S.J. Duguid M.J. Shenfield G.M. (2002) The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian J Ageing 21: 36–41.
    • (2002) Australasian J Ageing , vol.21 , pp. 36-41
    • Bajorek, B.V.1    Krass, I.2    Ogle, S.J.3    Duguid, M.J.4    Shenfield, G.M.5
  • 2
    • 29244471575 scopus 로고    scopus 로고
    • Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention
    • Bajorek B.V. Krass I. Ogle S.J. Duguid M.J. Shenfield G.M. (2005) Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention. J Am Geriatrics Soc 53: 1912–1920.
    • (2005) J Am Geriatrics Soc , vol.53 , pp. 1912-1920
    • Bajorek, B.V.1    Krass, I.2    Ogle, S.J.3    Duguid, M.J.4    Shenfield, G.M.5
  • 3
    • 33847733976 scopus 로고    scopus 로고
    • Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers
    • Bajorek B.V. Ogle S.J. Duguid M.J. Shenfield G.M. Krass I. Bajorek B.V. (2007) Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Med J Australia 186: 175–180.
    • (2007) Med J Australia , vol.186 , pp. 175-180
    • Bajorek, B.V.1    Ogle, S.J.2    Duguid, M.J.3    Shenfield, G.M.4    Krass, I.5    Bajorek, B.V.6
  • 4
    • 0028299731 scopus 로고
    • Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study
    • Benjamin E. Levy D. Vaziri D. D'Agostino R. Belanger A. Wolf P. (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. J Am Med Assoc 271: 840–844.
    • (1994) J Am Med Assoc , vol.271 , pp. 840-844
    • Benjamin, E.1    Levy, D.2    Vaziri, D.3    D'Agostino, R.4    Belanger, A.5    Wolf, P.6
  • 5
    • 0032144231 scopus 로고    scopus 로고
    • Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
    • Beyth R.J. Quinn L.M. Landefeld C.S. (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105: 91–99.
    • (1998) Am J Med , vol.105 , pp. 91-99
    • Beyth, R.J.1    Quinn, L.M.2    Landefeld, C.S.3
  • 6
    • 27744591199 scopus 로고    scopus 로고
    • The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy
    • 7 January 2005
    • Bond A. Molnar F. Li M. Mackey M. Man-Son-Hing M. (2005) The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy. Thrombosis J 3(1): 7 January 2005.
    • (2005) Thrombosis J , vol.3 , Issue.1
    • Bond, A.1    Molnar, F.2    Li, M.3    Mackey, M.4    Man-Son-Hing, M.5
  • 7
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
    • Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323: 1505–1511.
    • (1990) N Engl J Med , vol.323 , pp. 1505-1511
  • 8
    • 84993695789 scopus 로고    scopus 로고
    • Evaluating the impact of new anticoagulants in the hospital setting
    • in press.
    • Braidy N. Bui K. Bajorek B. (2010) Evaluating the impact of new anticoagulants in the hospital setting. Pharmacy Practice, in press.
    • (2010) Pharmacy Practice
    • Braidy, N.1    Bui, K.2    Bajorek, B.3
  • 10
    • 67249161108 scopus 로고    scopus 로고
    • Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services
    • Castelino R.L. Bajorek B.V. Chen T.F. (2009) Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services. Ann Pharmacother 43: 1096–1106.
    • (2009) Ann Pharmacother , vol.43 , pp. 1096-1106
    • Castelino, R.L.1    Bajorek, B.V.2    Chen, T.F.3
  • 11
    • 78751671680 scopus 로고    scopus 로고
    • Are interventions recommended by pharmacists during Home Medicines Review evidence-based?
    • Castelino R.L. Bajorek B.V. Chen T.F. (2011) Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Practice 17(1): 104–110.
    • (2011) J Eval Clin Practice , vol.17 , Issue.1 , pp. 104-110
    • Castelino, R.L.1    Bajorek, B.V.2    Chen, T.F.3
  • 12
    • 77956067146 scopus 로고    scopus 로고
    • Use of evidence-based therapy for the prevention of cardiovascular events among older people
    • Castelino R.L. Chen T.F. Guddattu V. Bajorek B.V. (2010) Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Professions 33: 276–301.
    • (2010) Eval Health Professions , vol.33 , pp. 276-301
    • Castelino, R.L.1    Chen, T.F.2    Guddattu, V.3    Bajorek, B.V.4
  • 13
    • 9144258391 scopus 로고    scopus 로고
    • Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: The PROGRESS Trial
    • Chapman N. Huxley R. Anderson C. Bousser M.G. Chalmers J. Colman S. (2004) Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: The PROGRESS Trial. Stroke 35: 116–121.
    • (2004) Stroke , vol.35 , pp. 116-121
    • Chapman, N.1    Huxley, R.2    Anderson, C.3    Bousser, M.G.4    Chalmers, J.5    Colman, S.6
  • 15
    • 57149140461 scopus 로고    scopus 로고
    • Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
    • Connolly S.J. Pogue J. Eikelboom J. Flaker G. Commerford P. Franzosi M.G. (2008) Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 118: 2029–2037.
    • (2008) Circulation , vol.118 , pp. 2029-2037
    • Connolly, S.J.1    Pogue, J.2    Eikelboom, J.3    Flaker, G.4    Commerford, P.5    Franzosi, M.G.6
  • 16
    • 0035944374 scopus 로고    scopus 로고
    • Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation
    • Copland M. Walker I. Tait R. (2001) Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med 161: 2125–2128.
    • (2001) Arch Intern Med , vol.161 , pp. 2125-2128
    • Copland, M.1    Walker, I.2    Tait, R.3
  • 18
    • 77649254746 scopus 로고    scopus 로고
    • Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
    • e341
    • Eikelboom J.W. O'Donnell M. Yusuf S. Diaz R. Flaker G. Hart R. (2010) Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. Am Heart J 159: 348–353.e341.
    • (2010) Am Heart J , vol.159 , pp. 348-353
    • Eikelboom, J.W.1    O'Donnell, M.2    Yusuf, S.3    Diaz, R.4    Flaker, G.5    Hart, R.6
  • 20
    • 77956440922 scopus 로고    scopus 로고
    • Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    • Escobar C. Barrios V. Jimenez D. (2010) Atrial fibrillation and dabigatran: has the time come to use new anticoagulants? Cardiovasc Therapeut 28: 295–301.
    • (2010) Cardiovasc Therapeut , vol.28 , pp. 295-301
    • Escobar, C.1    Barrios, V.2    Jimenez, D.3
  • 21
    • 64449086510 scopus 로고    scopus 로고
    • Antithrombotic therapy for the treatment of atrial fibrillation in the elderly
    • Fang M. (2009) Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Intervent Cardiol Electrophysiol 25: 19–23.
    • (2009) J Intervent Cardiol Electrophysiol , vol.25 , pp. 19-23
    • Fang, M.1
  • 22
    • 39149084073 scopus 로고    scopus 로고
    • Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
    • Fang M. Go A. Chang Y. Borowsky L. Pomernacki N. Singer D. (2008) Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am College Cardiol 51: 810–815.
    • (2008) J Am College Cardiol , vol.51 , pp. 810-815
    • Fang, M.1    Go, A.2    Chang, Y.3    Borowsky, L.4    Pomernacki, N.5    Singer, D.6
  • 23
    • 33746765044 scopus 로고    scopus 로고
    • Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study
    • Fang M.C. Go A.S. Hylek E.M. Chang Y. Henault L.E. Jensvold N.G. (2006) Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatrics Soc 54: 1231–1236.
    • (2006) J Am Geriatrics Soc , vol.54 , pp. 1231-1236
    • Fang, M.C.1    Go, A.S.2    Hylek, E.M.3    Chang, Y.4    Henault, L.E.5    Jensvold, N.G.6
  • 24
    • 79551589662 scopus 로고    scopus 로고
    • Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation
    • Freeman J.V. Zhu R.P. Owens D.K. Garber A.M. Hutton D.W. Go A.S. (2011) Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med 154(1): 1–11.
    • (2011) Ann Intern Med , vol.154 , Issue.1 , pp. 1-11
    • Freeman, J.V.1    Zhu, R.P.2    Owens, D.K.3    Garber, A.M.4    Hutton, D.W.5    Go, A.S.6
  • 25
    • 19544361856 scopus 로고    scopus 로고
    • Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall
    • Gage B.F. (2005) Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 118: 612–617.
    • (2005) Am J Med , vol.118 , pp. 612-617
    • Gage, B.F.1
  • 26
    • 6444240752 scopus 로고    scopus 로고
    • Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
    • Gage B.F. van Walraven C. Pearce L. Hart R.G. Koudstaal P.J. Boode B.S.P. (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110: 2287–2292.
    • (2004) Circulation , vol.110 , pp. 2287-2292
    • Gage, B.F.1    van Walraven, C.2    Pearce, L.3    Hart, R.G.4    Koudstaal, P.J.5    Boode, B.S.P.6
  • 27
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    • Gage B.F. Yan Y. Milligan P.E. Waterman A.D. Culverhouse R. Rich M.W. (2006) Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151: 713–719.
    • (2006) Am Heart J , vol.151 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3    Waterman, A.D.4    Culverhouse, R.5    Rich, M.W.6
  • 28
    • 49849084379 scopus 로고    scopus 로고
    • Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
    • Gallagher A. Rietbrock S. Plumb J. van Staa T. (2008) Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thrombosis Haemostasis 6: 1500–1506.
    • (2008) J Thrombosis Haemostasis , vol.6 , pp. 1500-1506
    • Gallagher, A.1    Rietbrock, S.2    Plumb, J.3    van Staa, T.4
  • 29
    • 42049099458 scopus 로고    scopus 로고
    • Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls
    • Garwood C.L. Corbett T.L. (2008) Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother 42: 523–532.
    • (2008) Ann Pharmacother , vol.42 , pp. 523-532
    • Garwood, C.L.1    Corbett, T.L.2
  • 31
    • 38149065429 scopus 로고    scopus 로고
    • Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians
    • Gattellari M. Worthington J. Zwar N. Middleton S. (2008) Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke 39: 227–230.
    • (2008) Stroke , vol.39 , pp. 227-230
    • Gattellari, M.1    Worthington, J.2    Zwar, N.3    Middleton, S.4
  • 32
    • 60549096887 scopus 로고    scopus 로고
    • Potentially preventable strokes in high risk patients with atrial fibrillation who are not adequately anticoagulated
    • Gladstone D. Bui E. Fang B. Laupacis A. Lindsay M. Tu J. (2009) Potentially preventable strokes in high risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40: 235–240.
    • (2009) Stroke , vol.40 , pp. 235-240
    • Gladstone, D.1    Bui, E.2    Fang, B.3    Laupacis, A.4    Lindsay, M.5    Tu, J.6
  • 33
    • 33846970908 scopus 로고    scopus 로고
    • Newly detected atrial fibrillation and compliance with antithrombotic guidelines
    • Glazer N. Dublin S. Smith N. French B. Jackson L. Hrachovec J. (2007) Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med 167: 246–252.
    • (2007) Arch Intern Med , vol.167 , pp. 246-252
    • Glazer, N.1    Dublin, S.2    Smith, N.3    French, B.4    Jackson, L.5    Hrachovec, J.6
  • 34
    • 77955302969 scopus 로고    scopus 로고
    • Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
    • Guo Y. Wu Q. Zhang L. Yang T. Zhu P. Gao W. (2010) Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk? Clin Interventions Aging 5: 157–162.
    • (2010) Clin Interventions Aging , vol.5 , pp. 157-162
    • Guo, Y.1    Wu, Q.2    Zhang, L.3    Yang, T.4    Zhu, P.5    Gao, W.6
  • 35
    • 77956899158 scopus 로고    scopus 로고
    • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    • Hansen M. Sorensen R. Clausen M. Fog-Petersen M. Raunso J. Gadsboll N. (2010) Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170: 1433–1441.
    • (2010) Arch Intern Med , vol.170 , pp. 1433-1441
    • Hansen, M.1    Sorensen, R.2    Clausen, M.3    Fog-Petersen, M.4    Raunso, J.5    Gadsboll, N.6
  • 36
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart R.G. Pearce L.A. Aguilar M.I. (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146: 857–867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 37
    • 22044452252 scopus 로고    scopus 로고
    • Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas
    • Hart R.G. Tonarelli S.B. Pearce L.A. (2005) Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36: 1588–1593.
    • (2005) Stroke , vol.36 , pp. 1588-1593
    • Hart, R.G.1    Tonarelli, S.B.2    Pearce, L.A.3
  • 39
    • 0033562553 scopus 로고    scopus 로고
    • Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation
    • Howitt A. Armstrong D. (1999) Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. Br Med J 318: 1324–1327.
    • (1999) Br Med J , vol.318 , pp. 1324-1327
    • Howitt, A.1    Armstrong, D.2
  • 40
    • 41749123452 scopus 로고    scopus 로고
    • Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly
    • Jacobs L. (2008) Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Cardiol Clin 26: 157–167.
    • (2008) Cardiol Clin , vol.26 , pp. 157-167
    • Jacobs, L.1
  • 41
    • 33751240118 scopus 로고    scopus 로고
    • Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation
    • Kakar P. Lane D. Lip G.Y.H. (2006) Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation. Chest 130: 1296–1299.
    • (2006) Chest , vol.130 , pp. 1296-1299
    • Kakar, P.1    Lane, D.2    Lip, G.Y.H.3
  • 42
    • 35748970163 scopus 로고    scopus 로고
    • Letter to the Editor, “The management of atrial fibrillation
    • Kapoor J. (2007) Letter to the Editor, “The management of atrial fibrillation”. Lancet 370: 1608–1608.
    • (2007) Lancet , vol.370 , pp. 1608
    • Kapoor, J.1
  • 43
    • 0034928145 scopus 로고    scopus 로고
    • Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care
    • Krska J. Cromarty J. Arris F. Jamieson D. Hanford D. Duffus P. (2001) Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 30: 205–211.
    • (2001) Age Ageing , vol.30 , pp. 205-211
    • Krska, J.1    Cromarty, J.2    Arris, F.3    Jamieson, D.4    Hanford, D.5    Duffus, P.6
  • 44
    • 0033535397 scopus 로고    scopus 로고
    • Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism
    • Kuijer P.M.M. Hutten B.A. Prins M.H. Buller H.R. (1999) Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 159: 457–460.
    • (1999) Arch Intern Med , vol.159 , pp. 457-460
    • Kuijer, P.M.M.1    Hutten, B.A.2    Prins, M.H.3    Buller, H.R.4
  • 45
    • 12144264059 scopus 로고    scopus 로고
    • Anti-thrombotic therapy for atrial fibrillation and patients’ preferences for treatment
    • Lane D. Lip G.Y.H. (2005) Anti-thrombotic therapy for atrial fibrillation and patients’ preferences for treatment. Age Ageing 34: 1–3.
    • (2005) Age Ageing , vol.34 , pp. 1-3
    • Lane, D.1    Lip, G.Y.H.2
  • 46
    • 78650878679 scopus 로고    scopus 로고
    • Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score
    • Lip G.Y.H. Frison L. Halperin J.L. Lane D.A. (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score. J Am College Cardiol 57: 173–180.
    • (2011) J Am College Cardiol , vol.57 , pp. 173-180
    • Lip, G.Y.H.1    Frison, L.2    Halperin, J.L.3    Lane, D.A.4
  • 47
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach
    • Lip G.Y.H. Nieuwlaat R. Pisters R. Lane D.A. Crijns H.J.G.M. (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 137: 263–272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.H.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.G.M.5
  • 48
    • 0033548832 scopus 로고    scopus 로고
    • Choosing antithrombotic therapy for elderly persons with atrial fibrillation who are at risk for falls
    • Man-Son-Hing M. Nichol G. Lau A. Laupacis A. (1999) Choosing antithrombotic therapy for elderly persons with atrial fibrillation who are at risk for falls. Arch Intern Med 159: 677–685.
    • (1999) Arch Intern Med , vol.159 , pp. 677-685
    • Man-Son-Hing, M.1    Nichol, G.2    Lau, A.3    Laupacis, A.4
  • 49
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    • Mant J. Hobbs F.D.R. Fletcher K. Roalfe A. Fitzmaurice D. Lip G.Y.H. (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370: 493–503.
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.R.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.H.6
  • 50
    • 78649508381 scopus 로고    scopus 로고
    • Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards
    • Marcucci M. Iorio A. Nobili A. Tettamanti M. Pasina L. Marengoni A. (2010) Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med 21(6): 516–523.
    • (2010) Eur J Intern Med , vol.21 , Issue.6 , pp. 516-523
    • Marcucci, M.1    Iorio, A.2    Nobili, A.3    Tettamanti, M.4    Pasina, L.5    Marengoni, A.6
  • 51
    • 77955940982 scopus 로고    scopus 로고
    • Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis
    • Marinigh R. Lip G.Y.H. Fiotti N. Giansante C. Lane D.A. (2010) Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am College Cardiol 56: 827–837.
    • (2010) J Am College Cardiol , vol.56 , pp. 827-837
    • Marinigh, R.1    Lip, G.Y.H.2    Fiotti, N.3    Giansante, C.4    Lane, D.A.5
  • 53
    • 64749108509 scopus 로고    scopus 로고
    • Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
    • Morgan C.L. McEwan P. Tukiendorf A. Robinson P.A. Clemens A. Plumb J.M. (2009) Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control. Thrombosis Res 124: 37–41.
    • (2009) Thrombosis Res , vol.124 , pp. 37-41
    • Morgan, C.L.1    McEwan, P.2    Tukiendorf, A.3    Robinson, P.A.4    Clemens, A.5    Plumb, J.M.6
  • 54
    • 84993804023 scopus 로고    scopus 로고
    • Patient education about warfarin therapy: a review of the knowledge, information needs and education of older patients
    • in press.
    • Nasser S. Mullan J. Bajorek B. (2010) Patient education about warfarin therapy: a review of the knowledge, information needs and education of older patients. Family Practice, in press.
    • (2010) Family Practice
    • Nasser, S.1    Mullan, J.2    Bajorek, B.3
  • 55
    • 61449167053 scopus 로고    scopus 로고
    • The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation
    • Perera V. Bajorek B.V. Matthews S. Hilmer S.N. (2009a) The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 38: 156–162.
    • (2009) Age Ageing , vol.38 , pp. 156-162
    • Perera, V.1    Bajorek, B.V.2    Matthews, S.3    Hilmer, S.N.4
  • 56
    • 61449167053 scopus 로고    scopus 로고
    • The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation
    • Perera V. Bajorek B.V. Matthews S. Hilmer S.N. Perera V. Bajorek B.V. (2009b) The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 38: 156–162.
    • (2009) Age Ageing , vol.38 , pp. 156-162
    • Perera, V.1    Bajorek, B.V.2    Matthews, S.3    Hilmer, S.N.4    Perera, V.5    Bajorek, B.V.6
  • 57
    • 0024543543 scopus 로고
    • Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study
    • Petersen P. Boysen G. Godtfredsen J. Andersen E. Andersen B. (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1: 175–179.
    • (1989) Lancet , vol.1 , pp. 175-179
    • Petersen, P.1    Boysen, G.2    Godtfredsen, J.3    Andersen, E.4    Andersen, B.5
  • 58
    • 0011814116 scopus 로고    scopus 로고
    • Rational drug usage in the elderly: walking the fine line between polypharmacy and undertreatment
    • Peterson G. (2001) Rational drug usage in the elderly: walking the fine line between polypharmacy and undertreatment. Australian Pharmacist 20: 248–254.
    • (2001) Australian Pharmacist , vol.20 , pp. 248-254
    • Peterson, G.1
  • 59
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey
    • Pisters R. Lane D.A. Nieuwlaat R. de Vos C.B. Crijns H.J.G.M. Lip G.Y.H. (2010) A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest 138(5): 1032–1033.
    • (2010) Chest , vol.138 , Issue.5 , pp. 1032-1033
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    de Vos, C.B.4    Crijns, H.J.G.M.5    Lip, G.Y.H.6
  • 60
    • 77953151936 scopus 로고    scopus 로고
    • Antithrombotic treatment before stroke onset and stroke severity in patients with atrial fibrillation and first-ever ischemic stroke: an observational study
    • Po H. Lin Y.-J. (2010) Antithrombotic treatment before stroke onset and stroke severity in patients with atrial fibrillation and first-ever ischemic stroke: an observational study. Neurol Asia 15: 11–17.
    • (2010) Neurol Asia , vol.15 , pp. 11-17
    • Po, H.1    Lin, Y.-J.2
  • 61
    • 34948856297 scopus 로고    scopus 로고
    • Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score
    • Poli D. Antonucci E. Marcucci R. Fatini C. Alterini B. Mannini L. (2007) Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score. Thrombosis Res 121: 347–352.
    • (2007) Thrombosis Res , vol.121 , pp. 347-352
    • Poli, D.1    Antonucci, E.2    Marcucci, R.3    Fatini, C.4    Alterini, B.5    Mannini, L.6
  • 62
    • 33947413877 scopus 로고    scopus 로고
    • A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenerians with atrial fibrillation (WASPO)
    • Rash A. Downes T. Portner R. Yeo W. Morgan N. Channer K. (2007) A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenerians with atrial fibrillation (WASPO). Age Ageing 36: 151–156.
    • (2007) Age Ageing , vol.36 , pp. 151-156
    • Rash, A.1    Downes, T.2    Portner, R.3    Yeo, W.4    Morgan, N.5    Channer, K.6
  • 64
    • 85058721877 scopus 로고    scopus 로고
    • Rivaroxaban–once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
    • ROCKET-AF Study Investigators. (2010) Rivaroxaban–once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study. Am Heart J 159: 340–347.e341.
    • (2010) Am Heart J , vol.159 , pp. 340-347.e341
  • 65
    • 78650825618 scopus 로고    scopus 로고
    • Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
    • Rothwell P. Fowkes F. Belch J. Ogawa H. Warlow C. Meade T. (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377: 31–41.
    • (2011) Lancet , vol.377 , pp. 31-41
    • Rothwell, P.1    Fowkes, F.2    Belch, J.3    Ogawa, H.4    Warlow, C.5    Meade, T.6
  • 66
    • 77957932391 scopus 로고    scopus 로고
    • Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation - Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)
    • Ruff C. Giugliano R. Antman E. Crugnale S. Bocanegra T. Mercuri M. (2010) Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation - Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 160: 635–641.e632.
    • (2010) Am Heart J , vol.160 , pp. 635-641.e632
    • Ruff, C.1    Giugliano, R.2    Antman, E.3    Crugnale, S.4    Bocanegra, T.5    Mercuri, M.6
  • 67
    • 33751255101 scopus 로고    scopus 로고
    • Development of a contemporary bleeding risk model for elderly warfarin recipients
    • Shireman T.I. Mahnken J.D. Howard P.A. Kresowik T.F. Hou Q. Ellerbeck E.F. (2006) Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 130: 1390–1396.
    • (2006) Chest , vol.130 , pp. 1390-1396
    • Shireman, T.I.1    Mahnken, J.D.2    Howard, P.A.3    Kresowik, T.F.4    Hou, Q.5    Ellerbeck, E.F.6
  • 68
    • 0029097933 scopus 로고
    • Fall-related injuries in anticoagulated stroke patients during inpatient rehabilitation
    • Stein J. Viramontes B. Kerrigan D. (1995) Fall-related injuries in anticoagulated stroke patients during inpatient rehabilitation. Arch Phys Med Rehabilitation 76: 840–843.
    • (1995) Arch Phys Med Rehabilitation , vol.76 , pp. 840-843
    • Stein, J.1    Viramontes, B.2    Kerrigan, D.3
  • 70
    • 0025914693 scopus 로고
    • The Stroke Prevention in Atrial Fibrillation Study: final results
    • Stroke Prevention in Atrial Fibrillation Investigators. (1991) The Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 84: 527–539.
    • (1991) Circulation , vol.84 , pp. 527-539
  • 71
    • 58849095355 scopus 로고    scopus 로고
    • Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation
    • Tincani E. Baldini P. Crowther M. Zanasi A. Ferrari P. Cenci A. (2009) Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Blood Coagulation Fibrinolysis 20: 47–51.
    • (2009) Blood Coagulation Fibrinolysis , vol.20 , pp. 47-51
    • Tincani, E.1    Baldini, P.2    Crowther, M.3    Zanasi, A.4    Ferrari, P.5    Cenci, A.6
  • 73
    • 77749289263 scopus 로고    scopus 로고
    • Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
    • Ufer M. (2010) Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. Thrombosis Haemostasis 103: 572–585.
    • (2010) Thrombosis Haemostasis , vol.103 , pp. 572-585
    • Ufer, M.1
  • 74
    • 32644442721 scopus 로고    scopus 로고
    • Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation
    • Valiya S.N. Bajorek B.V. (2005) Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation. J Pharm Practice Res 35: 279–283.
    • (2005) J Pharm Practice Res , vol.35 , pp. 279-283
    • Valiya, S.N.1    Bajorek, B.V.2
  • 75
    • 0027291892 scopus 로고
    • Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
    • Van der Meer F. Rosendaal F. Vandenbroucke J. Briet E. (1993) Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 153: 1557–1562.
    • (1993) Arch Intern Med , vol.153 , pp. 1557-1562
    • Van der Meer, F.1    Rosendaal, F.2    Vandenbroucke, J.3    Briet, E.4
  • 76
    • 77956977472 scopus 로고    scopus 로고
    • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
    • Wallentin L. Yusuf S. Ezekowitz M. Alings M. Flather F. Franzosi M. (2010) Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 376(9745): 975–983.
    • (2010) Lancet , vol.376 , Issue.9745 , pp. 975-983
    • Wallentin, L.1    Yusuf, S.2    Ezekowitz, M.3    Alings, M.4    Flather, F.5    Franzosi, M.6
  • 78
    • 0021739788 scopus 로고
    • The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study
    • Wintzen A.R. de Jonge H. Loeliger E.A. Bots G.T.A.M. (1984) The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study. Ann Neurol 16: 553–558.
    • (1984) Ann Neurol , vol.16 , pp. 553-558
    • Wintzen, A.R.1    de Jonge, H.2    Loeliger, E.A.3    Bots, G.T.A.M.4
  • 79
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • Wolf P.A. Abbott R.D. Kannel W.B. (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22: 983–988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.